GR3026166T3 - Conformationally locked nucleoside analogues - Google Patents
Conformationally locked nucleoside analoguesInfo
- Publication number
- GR3026166T3 GR3026166T3 GR980400341T GR980400341T GR3026166T3 GR 3026166 T3 GR3026166 T3 GR 3026166T3 GR 980400341 T GR980400341 T GR 980400341T GR 980400341 T GR980400341 T GR 980400341T GR 3026166 T3 GR3026166 T3 GR 3026166T3
- Authority
- GR
- Greece
- Prior art keywords
- nucleoside analogues
- conformationally locked
- cyclopropane
- compounds
- locked nucleoside
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12679693A | 1993-09-24 | 1993-09-24 | |
| PCT/US1994/010794 WO1995008541A1 (en) | 1993-09-24 | 1994-09-23 | Conformationally locked nucleoside analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3026166T3 true GR3026166T3 (en) | 1998-05-29 |
Family
ID=22426712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR980400341T GR3026166T3 (en) | 1993-09-24 | 1998-02-18 | Conformationally locked nucleoside analogues |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5629454A (el) |
| EP (1) | EP0720604B1 (el) |
| JP (1) | JP3481945B2 (el) |
| AT (1) | ATE160340T1 (el) |
| AU (1) | AU677441B2 (el) |
| DE (1) | DE69406943T2 (el) |
| DK (1) | DK0720604T3 (el) |
| ES (1) | ES2111960T3 (el) |
| GR (1) | GR3026166T3 (el) |
| WO (1) | WO1995008541A1 (el) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6766496A (en) * | 1996-08-07 | 1998-02-25 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Conformationally locked nucleoside analogs as antiherpetic agents |
| US5840728A (en) * | 1996-08-07 | 1998-11-24 | United States Of America As Represented By The Department Of Health And Human Services | Conformationally locked nucleoside analogs as antiherpetic agents |
| ATE336492T1 (de) | 2000-01-14 | 2006-09-15 | Us Gov Health & Human Serv | Methonocarbacycloalkylanaloga von nucleosiden |
| EP1305296B9 (en) * | 2000-07-26 | 2010-04-07 | The Government of the United States of America, as represented by the Secretary Department of Health and Human Services | 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| US20020187479A1 (en) * | 2001-06-12 | 2002-12-12 | Gayle Dace | In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads |
| US20030032028A1 (en) * | 2001-06-12 | 2003-02-13 | Gayle Dace | In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads |
| EP1509624A2 (en) * | 2002-05-31 | 2005-03-02 | Secretary, Department Of Atomic Energy | Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands |
| EP1546404A2 (en) * | 2002-09-11 | 2005-06-29 | Exiqon A/S | A population of nucleic acids including a subpopulation of lna oligomers |
| WO2006091905A1 (en) * | 2005-02-25 | 2006-08-31 | Gilead Sciences, Inc. | Bicyclo (3.1.0) hexane derivatives as antiviral compounds |
| WO2006128159A2 (en) | 2005-05-25 | 2006-11-30 | The Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses |
| WO2011068978A1 (en) | 2009-12-02 | 2011-06-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methanocarba adenosine derivatives and dendrimer conjugates thereof |
| EP3119789B1 (en) | 2014-03-17 | 2020-04-22 | Ionis Pharmaceuticals, Inc. | Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom |
| JP6546268B2 (ja) | 2014-08-04 | 2019-07-17 | オーバーン・ユニバーシティＡｕｂｕｒｎ Ｕｎｉｖｅｒｓｉｔｙ | ネプラノシンａの１’，６’−異性体の鏡像体 |
| KR101875997B1 (ko) | 2015-05-04 | 2018-07-06 | 엔 앤드 엔 파마세우티칼스 인크. | 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0577558A2 (de) * | 1992-07-01 | 1994-01-05 | Ciba-Geigy Ag | Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte |
-
1994
- 1994-09-23 DE DE69406943T patent/DE69406943T2/de not_active Expired - Lifetime
- 1994-09-23 WO PCT/US1994/010794 patent/WO1995008541A1/en active IP Right Grant
- 1994-09-23 JP JP50996195A patent/JP3481945B2/ja not_active Expired - Lifetime
- 1994-09-23 EP EP94929321A patent/EP0720604B1/en not_active Expired - Lifetime
- 1994-09-23 AU AU78420/94A patent/AU677441B2/en not_active Expired
- 1994-09-23 ES ES94929321T patent/ES2111960T3/es not_active Expired - Lifetime
- 1994-09-23 US US08/311,425 patent/US5629454A/en not_active Expired - Lifetime
- 1994-09-23 AT AT94929321T patent/ATE160340T1/de active
- 1994-09-23 DK DK94929321T patent/DK0720604T3/da active
-
1997
- 1997-03-14 US US08/818,563 patent/US5869666A/en not_active Expired - Lifetime
-
1998
- 1998-02-18 GR GR980400341T patent/GR3026166T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0720604T3 (da) | 1998-07-27 |
| ATE160340T1 (de) | 1997-12-15 |
| AU677441B2 (en) | 1997-04-24 |
| AU7842094A (en) | 1995-04-10 |
| WO1995008541A1 (en) | 1995-03-30 |
| JP3481945B2 (ja) | 2003-12-22 |
| US5629454A (en) | 1997-05-13 |
| JPH09502986A (ja) | 1997-03-25 |
| DE69406943T2 (de) | 1998-05-07 |
| US5869666A (en) | 1999-02-09 |
| DE69406943D1 (de) | 1998-01-02 |
| ES2111960T3 (es) | 1998-03-16 |
| EP0720604A1 (en) | 1996-07-10 |
| EP0720604B1 (en) | 1997-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3026166T3 (en) | Conformationally locked nucleoside analogues | |
| BR9609013A (pt) | Análogo de nucleosìdeos, e, composto. | |
| AU4690989A (en) | Antiviral cytosine and guanine derivatives | |
| CA2230059A1 (en) | Propargylethoxyamino nucleotides | |
| FI932870A0 (fi) | 2'-deoxi-2'2'-difluor-(4-substituerad pyrimidin)nukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter | |
| HUT59151A (en) | Process for producing purinylphosphonic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| IE900275L (en) | Antivirals and methods of increasing the antiviral activity¹of azt | |
| CA2054870A1 (en) | Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives | |
| CA2102782A1 (en) | 2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents | |
| DK1280813T3 (da) | Antivirale pyrimidin-nukleosidanaloger | |
| NZ227663A (en) | Purine nucleoside analogues, pyrimidine derivatives and pharmaceutical compositions | |
| SE8902568L (sv) | Antiviral komposition | |
| TW371662B (en) | Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives | |
| FI932868A0 (fi) | 2'-deoxi-2'2'-difluor(2,6,8-substituerade) purinnukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter | |
| FI885094A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisen 2',3'-dideoksi-3'-fluoripyrimidiini- tai -puriininukleosidin valmistamiseksi | |
| DK630589A (da) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning | |
| CA2172534A1 (en) | Conformationally locked nucleoside analogues | |
| KR960701639A (ko) | 심기능 회복제(heart function restorative) | |
| GB9506644D0 (en) | Preparation of nucleoside analogues | |
| JPS6422853A (en) | Nucleoside analog | |
| EP1138775A3 (en) | Method of preparing a guanosine-group compound and an intermediate thereof | |
| WO2001006986A3 (en) | 5-(e)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use | |
| IT1254519B (it) | Associazioni di composti ad attivita' antivirale | |
| Umnova et al. | Role of guanine derivatives in biosynthesis of uridine 5'-monophosphate in Brevibactrerium ammoniagenes | |
| WO1993000099A3 (de) | Verwendung von pyrimidin- und purinnucleosiden zur prophylaxe und/oder behandlung von durch adenoviren verursachten infektionen |